ASAMClinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids.

MLA

Weimer, Melissa B., et al. “ASAMClinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-Potency Synthetic Opioids.” Journal of Addiction Medicine, vol. 17, no. 6, Nov. 2023, pp. 632–39. EBSCOhost, https://doi.org/10.1097/ADM.0000000000001202.

APA

Weimer, M. B., Herring, A. A., Kawasaki, S. S., Meyer, M., Kleykamp, B. A., & Ramsey, K. S. (2023). ASAMClinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-potency Synthetic Opioids. Journal of Addiction Medicine, 17(6), 632–639. https://doi.org/10.1097/ADM.0000000000001202

Chicago

Weimer, Melissa B., Andrew A. Herring, Sarah S. Kawasaki, Marjorie Meyer, Bethea A. Kleykamp, and Kelly S. Ramsey. 2023. “ASAMClinical Considerations: Buprenorphine Treatment of Opioid Use Disorder for Individuals Using High-Potency Synthetic Opioids.” Journal of Addiction Medicine 17 (6): 632–39. doi:10.1097/ADM.0000000000001202.